Patents by Inventor MATTHEW TALLANT

MATTHEW TALLANT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic compounds
    Patent number: 8592395
    Abstract: The present invention relates to compounds of Formula (I) and (Ia) useful in the treatment of CCR5-related diseases and disorders, for example, the prevention or treatment of an HIV infection, and in the treatment of the resulting acquired immune deficiency syndrome (AIDS).
    Type: Grant
    Filed: July 23, 2010
    Date of Patent: November 26, 2013
    Assignee: GlaxoSmithKline LLC
    Inventors: Maosheng Duan, Wieslaw Mieczyslaw Kazmierski, Matthew Tallant
  • Chemical compounds
    Patent number: 8492554
    Abstract: Disclosed are compounds of Formula III. Also disclosed are salts of the compounds, pharmaceutical composition comprising the compounds or salts, and methods for treating HCV infection by administration of the compounds or salts.
    Type: Grant
    Filed: November 15, 2012
    Date of Patent: July 23, 2013
    Assignee: GlaxoSmithKline LLC
    Inventors: Pingyun Chen, Ricky Couch, Maosheng Duan, Richard Martin Grimes, Wieslaw Mieczyslaw Kazmierski, Beth Adams Norton, Matthew Tallant
  • Therapeutic Compounds
    Publication number: 20120295877
    Abstract: The present invention relates to compounds of Formula (I) and (Ia) useful in the treatment of CCR5-related diseases and disorders, for example, the prevention or treatment of an HIV infection, and in the treatment of the resulting acquired immune deficiency syndrome (AIDS).
    Type: Application
    Filed: July 23, 2010
    Publication date: November 22, 2012
    Inventors: Maosheng Duan, Wieslaw Mieczyslaw Kazmierski, Matthew Tallant
  • Chemical Compounds
    Publication number: 20110152237
    Abstract: Disclosed are compounds of Formula III. Also disclosed are salts of the compounds, pharmaceutical composition comprising the compounds or salts, and methods for treating HCV infection by administration of the compounds or salts.
    Type: Application
    Filed: August 26, 2010
    Publication date: June 23, 2011
    Inventors: Pingyun Chen, Ricky Couch, Maosheng Duan, Richard Martin Grimes, Wieslaw Mieczyslaw Kazmierski, Beth Adams Norton, Matthew Tallant, Pingyun Chen, Ricky Couch, Maosheng Duan, Richard Martin Grimes, Wleslaw Mieczyslaw Kazmierski, Beth Adams Norton, Matthew Tallant
  • COMPOUNDS
    Publication number: 20100196321
    Abstract: The present invention features compounds of Formula (I) and (Ia), pharmaceutical compositions and use in the treatment of viral disease:
    Type: Application
    Filed: January 28, 2010
    Publication date: August 5, 2010
    Applicant: GLAXOSMITHKLINE LLC
    Inventors: JOEL COOPER, MAOSHENG DUAN, RICHARD GRIMES, WIESLAW KAZMIERSKI, MATTHEW TALLANT